Actions of dopamine antagonists on stimulated striatal and limbic dopamine release: an in vivo voltammetric study
Open Access
- 18 July 1988
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 94 (3) , 924-932
- https://doi.org/10.1111/j.1476-5381.1988.tb11605.x
Abstract
1 Fast cyclic voltammetry at carbon fibre microelectrodes was used to study the effects of several dopamine antagonists upon stimulated dopamine release in the rat striatum and nucleus accumbens. 2 In both nuclei, stimulated dopamine release was increased by D2-receptor-selective and mixed D1/D2-receptor antagonists. The D1-selective antagonist SCH 23390 had no effect. 3 Striatal and limbic dopamine release were elevated by cis- but not trans-flupenthixol. 4 The ‘atypical’ neuroleptics (clozapine and thioridazine) did not cause a selective elevation of dopamine release in the limbic terminal region, whereas the non-antipsychotic drug metoclopramide increased dopamine release more in striatum than nucleus accumbens. 5 We conclude from this study that striatal and limbic dopamine release are under the control of a stereoselective dopamine D2-autoreceptor on the nerve terminal and that atypical neuroleptics do not show a limbic-selective effect at this receptor after acute administration.This publication has 51 references indexed in Scilit:
- Modulation of In Vivo Dopamine Release by D2 but Not D1 Receptor Agonists and AntagonistsJournal of Neurochemistry, 1987
- A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatumLife Sciences, 1985
- Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonistLife Sciences, 1985
- Two dopamine receptors: Biochemistry, physiology and pharmacologyLife Sciences, 1984
- Afferent and Efferent Relationships of the Basal GangliaPublished by Wiley ,1984
- Direct in Vivo Monitoring of Dopamine Released from Two Striatal Compartments in the RatScience, 1983
- Potent lipophilic substituted benzamide drugs are not selective D-1 dopamine receptor antagonists in the ratJournal of Pharmacy and Pharmacology, 1983
- Stereospecific binding of 3H-Dopamine in neostriatal membrane preparations: Inhibitory effects of sodium ascorbateLife Sciences, 1983
- Multiple receptors for dopamineNature, 1979
- Assessment of the neuroleptic potential of some novel benzamide, butyrophenone, phenothiazine and indole derivativesJournal of Pharmacy and Pharmacology, 1978